Primary nephrotic syndrome in adults, including minimal-change nephrotic syndrome, has an incidence of roughly 0.2 to 0.8 per ...

Topline data were announced from a phase 3 study evaluating obinutuzumab in patients between 2 and 25 years of age with idiopathic nephrotic syndrome.

One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...

One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic syndrome or ...

One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...

Paraneoplastic Syndrome, Lung Neoplasia, Electrolyte Imbalance, Geriatric Oncology, Palliative Care Share and Cite: Ramos, F.

Chronic Kidney Disease has become one of the world’s most serious yet often overlooked health threats, affecting more than ...

Chemo and surgery failed to treat Diane Davis' advanced cancer. Things seemed hopeless until genetic testing found an ...

The Liberation From Acute Dialysis (LIBERATE-D) randomized clinical trial tested the value of a conservative vs conventional hemodialysis strategy on recovery of kidney function in stable patients ...

Adding an investigational nonsteroidal mineralocorticoid receptor antagonist (MRA) to an SGLT2 inhibitor led to a superior ...

An estimated 50% of patients with SLE will develop lupus nephritis in their lifetime, with people of African descent more ...